Family-Centered Care for Domestic Violence
Trial Summary
What is the purpose of this trial?
The purpose of the study will be to determine how participation in Family-Centered Care (FCC) compared to Child-centered care (CCC) will affect caregiver engagement in IPV-based community services, caregiver perceptions of empowerment and survivor-defined practice, and clinical outcomes for children exposed to IPV.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Family-Centered Care for Domestic Violence?
Family-centered care (FCC) is widely used in pediatric health care and is considered the standard by many clinical practices, as it involves the whole family in care planning and decision-making. Although its effectiveness hasn't been systematically measured, it is believed to improve health outcomes by fostering a partnership between families and healthcare providers.12345
How is the Family-Centered Care treatment for domestic violence different from other treatments?
Family-Centered Care (FCC) is unique because it involves the entire family in the care process, focusing on participation, information sharing, and individualized care for each family member. This approach is different from traditional treatments that may focus solely on the individual, as it considers the impact on and involvement of the whole family.13467
Research Team
Gunjan Tiyyagura, MD, MHS
Principal Investigator
Yale University
Eligibility Criteria
This trial is for parents over 18 with a child under 3 who's been exposed to domestic violence and reported to Child Protective Services. Participants must speak English or Spanish, agree to a medical evaluation for the child, and not already be connected to an IPV advocate or be a ward of the state.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Initial Visit and Assessment
Participants undergo initial assessment and receive either family-focused care or child-focused care
Follow-up
Participants are monitored for engagement in IPV-based community services and clinical outcomes for children
Evaluation and Outcome Measurement
Evaluation of caregiver engagement, empowerment, and child clinical outcomes
Treatment Details
Interventions
- CCC (Behavioral Intervention)
- FCC (Behavioral Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Yale University
Lead Sponsor
Nancy J. Brown
Yale University
Chief Medical Officer since 2020
MD from Yale School of Medicine
Peter Salovey
Yale University
Chief Executive Officer since 2013
PhD in Psychology from Yale University
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborator
Dr. Diana W. Bianchi
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Chief Executive Officer since 2016
MD from Stanford University
Dr. Alison Cernich
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Chief Medical Officer since 2020
PhD in Clinical Psychology from University of Maryland